ClinicalMetric / Countries / Czech Republic
← All Countries
🇨🇿
COUNTRY FEED

Clinical Trials in Czech Republic

Active recruiting clinical trials with sites in Czech Republic. Select a condition below to see detailed trial listings.

Total Trials: 62 // Recruiting: 62 // Updated: Daily

Czech Republic currently has 62 clinical trials with at least one registered site in the country, of which 62 are actively recruiting participants. The most studied conditions at Czech Republic sites are Heart Failure, Delivery, Atrial Fibrillation (AF), reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including University Hospital Ostrava, General University Hospital, Prague, Charles University, Czech Republic. By stage, active Czech Republic trials break down as Phase 1 (2), Phase 2 (8), Phase 3 (3), Phase 4 (2). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Czech Republic

Heart Failure 2 Delivery 2 Atrial Fibrillation (AF) 2 Obesity 2 Prostate Cancer Patients 2 Parkinson Disease 2 C3 Glomerulopathy (C3G) 1 Healthy Adult Participants 1 Genetic Predisposition to Disease 1 Fluid Therapy 1 Microcirculation 1 Hemodilution 1 Hematologic Malignancy 1 Obstructive Sleep Apnea 1 Ventricular Tachycardia 1 Allogeneic HSCT 1 Posttransplant Complications 1 GvHD 1 Relapse 1 Acute Myeloid Leukemia 1
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology